Salubrinal, a specific inhibitor of the PERK pathway, inhibits dengue-induced increase of calreticulin at 24 h post infection (HPI) but only barely reduces the high level of calreticulin induced by tunicamycin (Figure 1a). This evidence concerns the gene CALR and dengue disease.